PET performed with a new imaging agent finds more prostate cancer than other modalities, including CT, MRI, and PET with conventional radiotracers, according to a study presented at this week’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting. {read more here}
SNMMI: FDG-PET/CT predicts ovarian cancer survival
FDG-PET/CT scans can help predict disease progression and overall survival of ovarian cancer patients for as long as several years after treatment, according to a Tuesday presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. {read more here}
FDG-PET and FDG-PET/CT do a good job in predicting the chances of recurrence and survival for patients with head and neck cancer within two years of completing chemotherapy treatment, according to a study presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. {read more here}
“In light of a current trend toward legalizing marijuana, with potentially increased exposure of adolescents, we believe our findings are important to consider,” said investigator Jodi Weinstein, MD, from the Columbia University Medical Center and the New York State Psychiatric Institute in New York City. {read more here}
Radiology, Molecular Imaging